Medisobiznews: 松岛 Bio Complex: A highly mature, commercialization-oriented bio cluster
Among 韩国's biomedical clusters, the 松岛 Bio Complex has been recognized as a highly mature production and commercialization-oriented complex. This type is similar to those like 旧金山, Ireland's NIBRT, and 新加坡's Tuas — and while slightly less mature compared to those clusters, it scored highly in terms of commercialization and is considered to have strong potential for future development.
◇松岛 Bio Complex: The key focus areas are specialized in 生物类似药s, 生物制药s, and CMO, with major companies as the core and favorable trade conditions due to proximity to the port and 仁川 Airport.
Participating medical institutions include Gil Hospital and Inha University Hospital, with universities such as 根特大学, 延世大学, 犹他大学, 仁川 Catholic University, University of 仁川, Inha University, 嘉泉大学, SUNY 韩国, and George Mason University 韩国 training approximately 4,500 personnel annually.
Participating 研究所s include the Lee Gil-ya Cancer and Diabetes Institute, 嘉泉大学医学院 Brain Science Institute, and private 研究所s (Samsung Bioepis, SCM Life Science, Utah-Inha DDS Research Institute, Voronoi, and RudaCure), which conduct basic research.
Source: Medisobiznews (http://www.medisobizanews.com)
